Financhill
Sell
34

DDOG Quote, Financials, Valuation and Earnings

Last price:
$138.06
Seasonality move :
-14.93%
Day range:
$135.11 - $139.65
52-week range:
$81.63 - $201.69
Dividend yield:
0%
P/E ratio:
467.62x
P/S ratio:
15.52x
P/B ratio:
14.08x
Volume:
2M
Avg. volume:
4.1M
1-year change:
-6.98%
Market cap:
$48.4B
Revenue:
$2.7B
EPS (TTM):
$0.30

DDOG Analysts' Consensus Rating

The 36 analysts providing 12-month price projections for Datadog, Inc. shares anticipate an average target of $212.33, ranging from a low estimate of $150.00 to a high estimate of $260.00. This average target implies a growth of 53.82% compared to the current stock price of $138.04.

Consensus Price Target

$212.33

Highest Price Target

$260.00

Lowest Price Target

$150.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 28 30 31

Hold 8 7 5

Sell 0 1 0
Consensus Buy Buy Buy

DDOG Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock